a trend toward significancep = .153
1b ) increased with disease severity with a trend toward significance (moderate, 1027.56 pg/mL; severe, 1136.92 pg/mL; critical, 1315.68 pg/mL, p = .153), and levels also rose post-tocilizumab (moderate, 1525 pg/mL, p = .011; severe, 1402.68 pg/mL, p = .046; critical, 1776.24 pg/mL, p = .0019).